Novavax final results show 96% efficacy in UK trial but plunge to about 50% in South African variant
Matching Pfizer and Moderna, Novavax unveiled final results Thursday afternoon from its Covid-19 vaccine trials in the UK and South Africa, showing its candidate proved …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
